Sir,

The use of a vaccine in recurrent corneal graft infection
The benefits to ophthalmology of vaccination have already become apparent. It has been shown that a herpes simplex vaccine seems able to reduce the number and duration of relapses of herpes simplex virus
I-related keratitis and keratouveitis.1 A vaccine against
Haemophilus inJluenzae has resulted in this organism no longer being a significant pathogen in periorbital or orbital cellulitis in vaccinated populations. [2] [3] [4] Microbial infection of a corneal graft can have devastating effects on the eye. There is a poor prognosis for graft survival and the regraft rate can be as high as 53%.s The percentage of grafts that remain clear after infective keratitis can be as low as 23%.s Streptococcus pneumoniae is a significant pathogen in microbial keratitis associated with penetrating keratoplasty.s Here we describe a novel approach to management of recurrent pneumococcal microbial keratitis in a corneal graft. It was considered that this patient was at high risk of developing further pneumococcal corneal ulcers in the grafted eye, and it was thought that her recurrent lung infections were due in part to Streptococcus pneumoniae. Vaccination should be considered in a patient who has had a pneumococcal keratitis. To prevent keratitis, there is a need to implement appropriate preventive measures as well as to monitor the graft closely after the operation;
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however, we think that, because of the risks associated with infections of a graft, pneumococcal vaccine could be considered as part of the pre-operative management of patients who are to have penetrating keratoplasty.
